Top medical groups from the US and abroad have persisted that doctors stop prescribing the diabetes drug Avandia, a product of GlaxoSmithKline.Members of the American Diabetes Association and the European Association for the Study of Diabetes decided unanimously against the use of the drug.
On Thursday, October 30, the consumer group Public Citizen asked the U.S. Food and Drug Administration to ban the drug.The group says that the usage of the drug increases the risk of heart attact, as well as causing 14 cases of liver failure resulting in 12 deaths.
GlaxoSmithKline responded by stating that they do not believe that there is a connection between liver failure and Avandia, and claims that the drup is safe and effective. Regardless of their claims, sells of the drug have dropped very significantly since last year.
The FDA is currently debating over whether to ban the drug completely or let is stay but with more warnings.
The petition from Public Citizen poses a very serious reputational risk that can cause GlaxoSmithKline a great deal of money in the future. The company should began taking steps in order to deal with restoring their reputation.
http://online.wsj.com/article/SB122537774874284331.html?mod=googlenews_wsj
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment